Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
This Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d’Azur, Nice, Franc...
Saved in:
: | |
---|---|
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 electronic resource (230 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993548231804498 |
---|---|
ctrlnum |
(CKB)4100000010106116 (oapen)https://directory.doabooks.org/handle/20.500.12854/61058 (EXLCZ)994100000010106116 |
collection |
bib_alma |
record_format |
marc |
spelling |
Hofman, Paul auth Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) Towards New Promising Discoveries for Lung Cancer Patients MDPI - Multidisciplinary Digital Publishing Institute 2019 1 electronic resource (230 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier This Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d’Azur, Nice, France) (Nice, September 2018). The central theme of JMLC is to discuss new advances and exchange ideas regarding lung cancer. Notably, the talks covered different topics on new therapeutic strategies (targeted therapy and immuno-oncology), molecular and cellular biology, biomarkers, and the epidemiology of lung cancer. Special attention was also given to lung cancer in elderly patients. The articles published in this Special Issue covered subjects such as the assessment of new biomarkers and new approaches for the early detection of lung cancer, epidemiological data, and emphasized a place for the newly characterized cellular pathways in lung cancer, which opens room for therapeutic perspectives for lung cancer patients. English microRNAs multiplexed screening education non-smoker image analysis artificial intelligence research lung cancer spatial analysis optimization fluorescence geriatric assessment geriatric interventions TNBC liquid biopsy non-small cell lung cancer integrated approaches well-being hormone-like action EGFR mutations reversal of EMT tumor plasticity immune profiling macrophage multiplexed methodologies targeted treatment techniques immune-oncology bioinformatics MALAT1 long non-coding RNAs CD8 T Cells personal medicine EGFR TKIs lncRNA hormones elderly interleukin-1? and immunometabolism chromogenic xenograft metastasis PD-1/PD-L1 checkpoint blockade immunotherapy molecular cancer tissues digital NSCLC immune blockade lung adenocarcinoma circulating tumor cells brightfield non-coding RNAs older adults cancer tumor microenvironment aging rational therapy 3-03921-451-9 Calin, George auth Mani, Sendurai auth |
language |
English |
format |
eBook |
author |
Hofman, Paul |
spellingShingle |
Hofman, Paul Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) |
author_facet |
Hofman, Paul Calin, George Mani, Sendurai |
author_variant |
p h ph |
author2 |
Calin, George Mani, Sendurai |
author2_variant |
g c gc s m sm |
author_sort |
Hofman, Paul |
title |
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) |
title_full |
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) |
title_fullStr |
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) |
title_full_unstemmed |
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) |
title_auth |
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) |
title_alt |
Towards New Promising Discoveries for Lung Cancer Patients |
title_new |
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) |
title_sort |
towards new promising discoveries for lung cancer patients: a selection of papers from the first joint meeting on lung cancer of the fhu oncoage (nice, france) and the md anderson cancer center (houston, tx, usa) |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2019 |
physical |
1 electronic resource (230 p.) |
isbn |
3-03921-452-7 3-03921-451-9 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT hofmanpaul towardsnewpromisingdiscoveriesforlungcancerpatientsaselectionofpapersfromthefirstjointmeetingonlungcancerofthefhuoncoagenicefranceandthemdandersoncancercenterhoustontxusa AT calingeorge towardsnewpromisingdiscoveriesforlungcancerpatientsaselectionofpapersfromthefirstjointmeetingonlungcancerofthefhuoncoagenicefranceandthemdandersoncancercenterhoustontxusa AT manisendurai towardsnewpromisingdiscoveriesforlungcancerpatientsaselectionofpapersfromthefirstjointmeetingonlungcancerofthefhuoncoagenicefranceandthemdandersoncancercenterhoustontxusa AT hofmanpaul towardsnewpromisingdiscoveriesforlungcancerpatients AT calingeorge towardsnewpromisingdiscoveriesforlungcancerpatients AT manisendurai towardsnewpromisingdiscoveriesforlungcancerpatients |
status_str |
n |
ids_txt_mv |
(CKB)4100000010106116 (oapen)https://directory.doabooks.org/handle/20.500.12854/61058 (EXLCZ)994100000010106116 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1792756686652440577 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03940nam-a2200997z--4500</leader><controlfield tag="001">993548231804498</controlfield><controlfield tag="005">20231214132826.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03921-452-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010106116</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/61058</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010106116</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hofman, Paul</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Towards New Promising Discoveries for Lung Cancer Patients</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (230 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d’Azur, Nice, France) (Nice, September 2018). The central theme of JMLC is to discuss new advances and exchange ideas regarding lung cancer. Notably, the talks covered different topics on new therapeutic strategies (targeted therapy and immuno-oncology), molecular and cellular biology, biomarkers, and the epidemiology of lung cancer. Special attention was also given to lung cancer in elderly patients. The articles published in this Special Issue covered subjects such as the assessment of new biomarkers and new approaches for the early detection of lung cancer, epidemiological data, and emphasized a place for the newly characterized cellular pathways in lung cancer, which opens room for therapeutic perspectives for lung cancer patients.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microRNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiplexed</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">screening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">education</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-smoker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">image analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">artificial intelligence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">research</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">spatial analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">optimization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluorescence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">geriatric assessment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">geriatric interventions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TNBC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquid biopsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-small cell lung cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">integrated approaches</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">well-being</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hormone-like action</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EGFR mutations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">reversal of EMT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor plasticity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune profiling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">macrophage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiplexed methodologies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">techniques</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune-oncology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioinformatics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MALAT1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">long non-coding RNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CD8 T Cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personal medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EGFR TKIs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lncRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hormones</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">elderly</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interleukin-1? and immunometabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chromogenic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">xenograft</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-1/PD-L1 checkpoint blockade</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer tissues</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">digital</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NSCLC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune blockade</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung adenocarcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circulating tumor cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brightfield</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-coding RNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">older adults</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor microenvironment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rational therapy</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03921-451-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calin, George</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mani, Sendurai</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-03-06 05:13:33 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-02-01 22:26:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338822090004498&Force_direct=true</subfield><subfield code="Z">5338822090004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338822090004498</subfield></datafield></record></collection> |